The Turing-Roche Strategic Partnership

The Alan Turing Institute and Roche officially set up a five year strategic partnership in June 2021. The 'North Star' of our partnership is to enable the generation of insights to better understand patient and disease heterogeneity and its relevance to clinical outcomes at an unprecedented level of precision in order to improve clinical care.

We will be covering multiple research and community activities to work towards our North Star, as well as building strong connections and collaborations between the Alan Turing Institute, Roche and the wider community.

This channel hosts partnership video content and recordings from our events.